NCT06829186View on ClinicalTrials.gov

The Effect of Curcumin on Inflammatory Markers in Hemodialysis Patients

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2026

Conditions
Hemodialysis
Interventions
DIETARY_SUPPLEMENT

Curcumin (Longvida™)

patients will be suplemented during 3 months with longvida, 2 cap /8 hours

DRUG

Placebo

one capsules every 8 hours during 12 weeks

All Listed Sponsors
collaborator

Hospital Civil de Guadalajara

OTHER

lead

University of Guadalajara

OTHER